International Flavors & Fragrances Inc. (IFF)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Nourish Revenue	-	5.87B
Health & Biosciences Revenue	2.25B	2.21B
Scent Revenue	2.45B	2.44B
Pharma Solutions Revenue	-	961.00M
Revenue (Other)	6.38B	-
Revenue (Total)	11.07B	11.48B

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Nourish Adjusted Operating EBITDA	-	824.00M
Health & Biosciences Adjusted Operating EBITDA	596.00M	654.00M
Scent Adjusted Operating EBITDA	506.00M	518.00M
Pharma Solutions Adjusted Operating EBITDA	-	209.00M
Operating Income (Total)	-352.00M	766.00M

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Nourish Capital Expenditures	235.00M
Health & Biosciences Capital Expenditures	73.00M
Scent Capital Expenditures	70.00M
Pharma Solutions Capital Expenditures	85.00M

Updated Nov 4, 2025. Data Source: Fiscal.ai.